NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

georgebailey, Northwest Bio has stated the following about Sawston expansion related to your question:

Our buildout of the Sawston facility is designed to proceed in phases, as modules, both for efficiency in the timing of capital costs and to allow flexibility in operations and usage.

We anticipate that implementation of the Flaskworks system will enable certain phases of the Sawston buildout to be simplified and streamlined.

So to answer your question: yes, of course I think Sawston is being designed and built out to incorporate the Flaskworks’ system in the manufacturing workflow - it will automate the primary part of the manufacturing process. Whether this occurs initially upon commercial startup, or shortly after, will obviously depend on the timing of the approval of the Flaskworks process.